title: Grape seed proanthocyanidins induce apoptosis through p53, Bax, and caspase 3 pathways.
abstract: Grape seed proanthocyanidins (GSP) have been shown to inhibit skin chemical carcinogenesis and photocarcinogenesis in mice. The mechanisms responsible for the anticarcinogenic effects of GSP are not clearly understood. Here, we report that treatment of JB6 C141 cells (a well-developed cell culture model for studying tumor promotion in keratinocytes) and p53+/+ fibroblasts with GSP resulted in a dose-dependent induction of apoptosis. GSP-induced (20-80 g/ml) apoptosis was observed by using immunofluorescence (27-90% apoptosis) and flow cytometry (18-87% apoptosis). The induction of apoptosis by GSP was p53-dependent because it occurred mainly in cells expressing wild-type p53 (p53+/+; 15-80%) to a much greater extent than in p53-deficient cells (p53-/-; 6-20%). GSP-induced apoptosis in JB6 C141 cells was associated with increased expression of the tumor-suppressor protein, p53, and its phosphorylation at Ser15. The antiapoptotic proteins, Bcl-2 and Bcl-xl, were downregulated by GSP, whereas the expression of the pro-apoptotic protein, Bax, and the levels of cytochrome c release, Apaf-1, caspase-9, and cleaved caspase 3 (p19 and p17) were markedly increased in JB6 C141 cells. The downregulation of Bcl-2 and upregulation of Bax were also observed in wild-type p53 (p53+/+) fibroblasts but was not observed in their p53-deficient counterparts. These data clearly demonstrate that GSP-induced apoptosis is p53-dependent and mediated through the Bcl-2, Bax, and caspase 3 pathways.
authors.affiliation: Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
authors.forename: Anshu M
authors.initials: AM
authors.lastname: Roy
authors.forename: Manjeshwar S
authors.initials: MS
authors.lastname: Baliga
authors.forename: Craig A
authors.initials: CA
authors.lastname: Elmets
authors.forename: Santosh K
authors.initials: SK
authors.lastname: Katiyar
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D053477:Apoptotic Protease-Activating Factor 1; D053148:Caspase 3; D020169:Caspases / Q000378:metabolism*; D002478:Cells, Cultured; D045304:Cytochromes c / Q000378:metabolism; D005347:Fibroblasts / Q000187:drug effects* / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D044945:Proanthocyanidins / Q000494:pharmacology*; D011506:Proteins / Q000378:metabolism; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism*; D012639:Seeds / Q000737:chemistry; D015398:Signal Transduction; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*; D027843:Vitis / Q000737:chemistry*; D051028:bcl-2-Associated X Protein; D051020:bcl-X Protein
chemical_list: C506593:Apaf1 protein, mouse; D053477:Apoptotic Protease-Activating Factor 1; C494827:Bax protein, mouse; C494812:Bcl2l1 protein, mouse; D044945:Proanthocyanidins; D011506:Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D016159:Tumor Suppressor Protein p53; D051028:bcl-2-Associated X Protein; D051020:bcl-X Protein; D045304:Cytochromes c; C505409:Casp3 protein, mouse; D053148:Caspase 3; D020169:Caspases
references.citation: Cancer Res. 2003 Aug 1;63(15):4396-401
references.pmid: 12907610
references.citation: Genes Dev. 2001 Nov 15;15(22):2922-33
references.pmid: 11711427
references.citation: Cancer Res. 1991 Dec 1;51(23 Pt 1):6304-11
references.pmid: 1933891
references.citation: EMBO J. 1997 Mar 17;16(6):1391-400
references.pmid: 9135154
references.citation: Nature. 1979 Oct 18;281(5732):589-91
references.pmid: 492322
references.citation: Cell. 1997 Oct 31;91(3):325-34
references.pmid: 9363941
references.citation: Cell. 2004 Jan 23;116(2):235-46
references.pmid: 14744434
references.citation: Carcinogenesis. 2003 Aug;24(8):1379-88
references.pmid: 12807737
references.citation: Biochem Pharmacol. 2003 Oct 15;66(8):1547-54
references.pmid: 14555233
references.citation: Nature. 1992 Mar 19;356(6366):215-21
references.pmid: 1552940
references.citation: Curr Opin Cell Biol. 2001 Jun;13(3):332-7
references.pmid: 11343904
references.citation: Carcinogenesis. 1999 Feb;20(2):237-42
references.pmid: 10069459
references.citation: Science. 1997 Feb 21;275(5303):1132-6
references.pmid: 9027315
references.citation: EMBO J. 1999 Dec 15;18(24):7002-10
references.pmid: 10601022
references.citation: Cell. 1996 Jul 12;86(1):147-57
references.pmid: 8689682
references.citation: Nucleic Acids Res. 1994 Sep;22(17):3551-5
references.pmid: 7937055
references.citation: Mol Cell Biochem. 1999 Jun;196(1-2):99-108
references.pmid: 10448908
references.citation: Curr Pharm Biotechnol. 2001 Jun;2(2):187-200
references.pmid: 11480422
references.citation: Free Radic Res. 2001 Aug;35(2):181-94
references.pmid: 11697199
references.citation: EMBO J. 1998 Aug 17;17(16):4657-67
references.pmid: 9707425
references.citation: Biochem Pharmacol. 1990 Nov 15;40(10):2353-62
references.pmid: 2244936
references.citation: Cell. 1994 Aug 26;78(4):539-42
references.pmid: 8069905
references.citation: Trends Pharmacol Sci. 1992 Jun;13(6):245-51
references.pmid: 1631963
references.citation: Cell. 1994 Aug 26;78(4):703-11
references.pmid: 8069917
references.citation: Toxicol Appl Pharmacol. 2001 Oct 15;176(2):110-7
references.pmid: 11601887
references.citation: J Immunol Methods. 1983 Dec 16;65(1-2):55-63
references.pmid: 6606682
references.citation: Nature. 1997 Feb 13;385(6617):637-40
references.pmid: 9024662
references.citation: J Med Food. 2003 Winter;6(4):291-9
references.pmid: 14977436
references.citation: Curr Opin Oncol. 1995 Nov;7(6):541-6
references.pmid: 8547403
references.citation: Breast Cancer Res Treat. 2004 May;85(1):1-12
references.pmid: 15039593
references.citation: Cancer Res. 1988 Mar 1;48(5):1195-200
references.pmid: 3342399
references.citation: Oncol Rep. 2004 Mar;11(3):681-5
references.pmid: 14767522
references.citation: Carcinogenesis. 2004 Jun;25(6):987-95
references.pmid: 14742313
references.citation: Genes Dev. 1999 Jan 15;13(2):152-7
references.pmid: 9925639
references.citation: Ann N Y Acad Sci. 2002 May;957:260-70
references.pmid: 12074978
references.citation: Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2345-9
references.pmid: 9122197
references.citation: Cell. 1989 Jun 30;57(7):1083-93
references.pmid: 2525423
references.citation: Oncogene. 2003 Mar 6;22(9):1302-16
references.pmid: 12618755
references.citation: Science. 1997 Feb 21;275(5303):1129-32
references.pmid: 9027314
references.citation: Cancer Lett. 1999 Jan 29;135(2):151-7
references.pmid: 10096423
references.citation: Carcinogenesis. 1999 Sep;20(9):1737-45
references.pmid: 10469619
references.citation: Oncogene. 1994 Dec;9(12):3743-51
references.pmid: 7970735
references.citation: Cell. 1993 Aug 27;74(4):609-19
references.pmid: 8358790
references.citation: FASEB J. 1994 Jun;8(9):654-60
references.pmid: 8005393
references.citation: Int J Oncol. 2004 Mar;24(3):703-10
references.pmid: 14767556
references.citation: Ann Genet. 1994;37(3):121-34
references.pmid: 7847793
references.citation: Prostate. 1997 Sep 1;32(4):284-93
references.pmid: 9288188
references.citation: Cancer Metastasis Rev. 1992 Sep;11(2):121-39
references.pmid: 1327566
references.citation: Int J Cancer. 2004 Feb 20;108(5):733-40
references.pmid: 14696100
references.citation: Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6252-6
references.pmid: 11972044
references.citation: Science. 1998 Sep 25;281(5385):2027-31
references.pmid: 9748162
references.citation: Leukemia. 2001 Apr;15(4):515-22
references.pmid: 11368354
references.citation: Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2026-30
references.pmid: 8134344
references.citation: Biochim Biophys Acta. 2004 Mar 1;1644(2-3):133-47
references.pmid: 14996498